Ying Zhang

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Nature

Nature immunology

Boston Children's Hospital

University of Pennsylvania (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Boston Children's Hospital Nov 14 2016

United States

Postdoctoral Research Fellow :: PCMM

Education History

University of Pennsylvania

United States

PHD :: School of Medicine

Publications

Ying Zhang, Pourya Naderi Yeganeh, Haiwei Zhang, Simon Yuan Wang, Zhouyihan Li, Bo-Wen Gu, Dian-Jang Lee, Zhibin Zhang, Athanasios Ploumakis, Ming Shi, Hao Wu, Eric Lieberman Greer, Winston A Hide, Judy Lieberman
Tumor editing suppresses innate and adaptive antitumor immunity and is reversed by inhibiting DNA methylation. Nature immunology (2024)
Sumit Sen Santara, Dian-Jang Lee, Ângela C Crespo, Jun Jacob Hu, Caitlin Walker, Xiyu Ma, Ying Zhang, Sourav Chowdhury, Karla F Meza-Sosa, Mercedes Lewandrowski, Haiwei Zhang, Marjorie Rowe, Arthur A McClelland, Hao Wu, Caroline Junqueira, Judy Lieberman
Publisher Correction: The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells. Nature (2023)
Sumit Sen Santara, Dian-Jang Lee, Ângela C Crespo, Jun Jacob Hu, Caitlin Walker, Xiyu Ma, Ying Zhang, Sourav Chowdhury, Karla F Meza-Sosa, Mercedes Lewandrowski, Haiwei Zhang, Marjorie Rowe, Arthur A McClelland, Hao Wu, Caroline Junqueira, Judy Lieberman
The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells. Nature (2023)
Setu M Vora, Pietro Fontana, Tianyang Mao, Valerie Leger, Ying Zhang, Tian-Min Fu, Judy Lieberman, Lee Gehrke, Ming Shi, Longfei Wang, Akiko Iwasak, Hao Wu
Targeting stem-loop 1 of the SARS-CoV-2 5' UTR to suppress viral translation and Nsp1 evasion. Proceedings of the National Academy of Sciences of the United States of America 119 (9) (2022)
Ying Zhang, Xuemei Xie, Pourya Naderi Yeganeh, Dian-Jang Lee, David Valle-Garcia, Karla F Meza-Sosa, Caroline Junqueira, Jiayu Su, Hongbo R Luo, Winston A Hide, Judy Lieberman
Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown. Proceedings of the National Academy of Sciences of the United States of America 118 (9) (2021)
Jun Jacob Hu, Xing Liu, Shiyu Xia, Zhibin Zhang, Ying Zhang, Jingxia Zhao, Jianbin Ruan, Xuemei Luo, Xiwen Lou, Yang Bai, Junhong Wang, L Robert Hollingsworth, Venkat Giri Magupalli, Li Zhao, Hongbo R Luo, Justin Kim, Judy Lieberman, Hao Wu
FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nature immunology 21 (7) (2020)

Ying Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ying Zhang